Pentosidine and Nε-(carboxymethyl)-lysine in Alzheimer’s disease and vascular dementia
- 21 September 2002
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 24 (2) , 333-338
- https://doi.org/10.1016/s0197-4580(02)00086-6
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Active glycation in neurofibrillary pathology of Alzheimer disease: Nε-(Carboxymethyl) lysine and hexitol-lysineFree Radical Biology & Medicine, 2001
- Oxidized Proteins in Alzheimer's PlasmaBiochemical and Biophysical Research Communications, 2000
- Lipoprotein(a) Phenotypes in Patients with Vascular DementiaDementia and Geriatric Cognitive Disorders, 2000
- Localization of identified advanced glycation end‐product structures, Nε=(carboxymethyl)lysine and pentosidine, in age‐related inclusions in human brainsPathology International, 1998
- Oxidative Stress Hypothesis in Alzheimer's DiseasePublished by Elsevier ,1998
- Alzheimer's disease – synergistic effects of glucose deficit, oxidative stress and advanced glycation endproductsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
- New biomarkers of Maillard reaction damage to proteinsNephrology Dialysis Transplantation, 1996
- Psychometrics in aging and dementia: advances in geropsychological assessmentsArchives of Gerontology and Geriatrics, 1985
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984